Germany
Japan
United Kingdom
China
Lenti ORF particles, CARD9 (mGFP-tagged) - Human caspase recruitment domain family, member 9 (CARD9), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lentiviral Particles
USD 1,020.00
6 Weeks
Lenti ORF particles, PPARA (Myc-DDK tagged) - Human peroxisome proliferator-activated receptor alpha (PPARA), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, FKBP8 (Myc-DDK tagged) - Human FK506 binding protein 8, 38kDa (FKBP8), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, GPR119 (Myc-DDK tagged) - Human G protein-coupled receptor 119 (GPR119), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MFGE8 (Myc-DDK tagged) - Human milk fat globule-EGF factor 8 protein (MFGE8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, VSIG4 (mGFP-tagged) - Human V-set and immunoglobulin domain containing 4 (VSIG4), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, SH2B3 (Myc-DDK tagged) - Human SH2B adaptor protein 3 (SH2B3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, SRSF5 (Myc-DDK tagged) - Human serine/arginine-rich splicing factor 5 (SRSF5), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SLC34A2 (Myc-DDK tagged) - Human solute carrier family 34 (sodium phosphate), member 2 (SLC34A2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, SLC34A2 (mGFP-tagged) - Human solute carrier family 34 (sodium phosphate), member 2 (SLC34A2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, TNFRSF25 (mGFP-tagged) - Human tumor necrosis factor receptor superfamily, member 25 (TNFRSF25), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,524.00
5 Weeks
Lenti ORF particles, IKBKB (Myc-DDK tagged) - Human inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (IKBKB), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SOX5 (Myc-DDK tagged) - Human SRY (sex determining region Y)-box 5 (SOX5), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,152.00
6 Weeks
Lenti ORF particles, TGFBR2 (Myc-DDK tagged) - Human transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,152.00
3 Weeks
Lenti ORF particles, TGFBR2 (mGFP-tagged) - Human transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PCSK9 (Myc-DDK tagged) - Human proprotein convertase subtilisin/kexin type 9 (PCSK9), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, PCSK9 (mGFP-tagged) - Human proprotein convertase subtilisin/kexin type 9 (PCSK9), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, PCSK9 (Myc-DDK tagged) - Human proprotein convertase subtilisin/kexin type 9 (PCSK9), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TRPV4 (mGFP-tagged) - Human transient receptor potential cation channel, subfamily V, member 4 (TRPV4), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TRPV4 (mGFP-tagged) - Human transient receptor potential cation channel, subfamily V, member 4 (TRPV4), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PTGER3 (Myc-DDK-tagged)-Human prostaglandin E receptor 3 (subtype EP3) (PTGER3), transcript variant 5, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PTGER3 (mGFP-tagged)-Human prostaglandin E receptor 3 (subtype EP3) (PTGER3), transcript variant 5, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CDCP1 (Myc-DDK tagged) - Human CUB domain containing protein 1 (CDCP1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CDCP1 (mGFP-tagged) - Human CUB domain containing protein 1 (CDCP1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, SLC18A2 (Myc-DDK tagged) - Human solute carrier family 18 (vesicular monoamine), member 2 (SLC18A2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, SLC18A2 (mGFP-tagged) - Human solute carrier family 18 (vesicular monoamine), member 2 (SLC18A2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,092.00
6 Weeks
Lenti ORF particles, SLC18A2 (Myc-DDK tagged) - Human solute carrier family 18 (vesicular monoamine), member 2 (SLC18A2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, SLC18A2 (mGFP-tagged) - Human solute carrier family 18 (vesicular monoamine), member 2 (SLC18A2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, POU3F4 (Myc-DDK tagged) - Human POU class 3 homeobox 4 (POU3F4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, ISM1 (Myc-DDK tagged) - Human isthmin 1 homolog (zebrafish) (ISM1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, ISM1 (mGFP-tagged) - Human isthmin 1 homolog (zebrafish) (ISM1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SLC7A14 (Myc-DDK tagged) - Human solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 (SLC7A14), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CTNND1 (Myc-DDK tagged) - Human catenin (cadherin-associated protein), delta 1 (CTNND1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, CTNND1 (mGFP-tagged) - Human catenin (cadherin-associated protein), delta 1 (CTNND1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, CTNND1 (mGFP-tagged) - Human catenin (cadherin-associated protein), delta 1 (CTNND1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, FUT8 (Myc-DDK tagged) - Human fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (FUT8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, FUT8 (Myc-DDK tagged) - Human fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (FUT8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, FUT8 (mGFP-tagged) - Human fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (FUT8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, GAD2 (Myc-DDK tagged) - Human glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) (GAD2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, GAD2 (mGFP-tagged) - Human glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) (GAD2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, GAD2 (Myc-DDK tagged) - Human glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) (GAD2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, GAD2 (mGFP-tagged) - Human glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) (GAD2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CMAS (mGFP-tagged) - Human cytidine monophosphate N-acetylneuraminic acid synthetase (CMAS), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CLEC12A (Myc-DDK tagged) - Human C-type lectin domain family 12, member A (CLEC12A), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, RGS3 (Myc-DDK tagged) - Human regulator of G-protein signaling 3 (RGS3), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, HIST1H1B (mGFP-tagged) - Human histone cluster 1, H1b (HIST1H1B), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, KIR3DL3 (Myc-DDK tagged) - Human killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3 (KIR3DL3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, TP53 (mGFP-tagged) - Human tumor protein p53 (TP53), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
6 Weeks
Lenti ORF particles, NF1 (Myc-DDK tagged) - Human neurofibromin 1 (NF1), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, YAP1 (mGFP-tagged)-Human Yes-associated protein 1 (YAP1), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Filter by
Target Symbol
- H2 (75)
- CREM (72)
- VEGFA (72)
- DISC1 (56)
- BDNF (54)
- MORF4L2 (52)
- HMGA1 (50)
- PDE9A (50)
- ASPH (48)
- NRG1 (48)
- BIN1 (46)
- NR1I3 (46)
- TCF7L2 (44)
- TPM1 (44)
- MBP (42)
- OPRM1 (42)
- CTNND1 (40)
- DTNA (40)
- FGFR1 (40)
- FGFR2 (40)
- ABI1 (38)
- CD46 (38)
- KCNQ2 (38)
- MEIS2 (38)
- PROM1 (38)
- CEACAM1 (36)
- FHL1 (36)
- GNAS (36)
- OSBPL9 (36)
- PDE4D (36)
- SYBU (36)
- ARPP21 (34)
- CD44 (34)
- TGIF1 (34)
- TP63 (34)
- ATXN3 (32)
- CAMK2B (32)
- HNRNPF (32)
- IGF1 (32)
- MITF (32)
- NREP (32)
- NRP2 (32)
- RTN4 (32)
- SYTL2 (32)
- TNNT2 (32)
- ADGRG2 (30)
- CELF2 (30)
- DAG1 (30)
- EIF5A (30)
- HNRNPD (30)
- IKBKG (30)
- MIER1 (30)
- NFATC1 (30)
- OXR1 (30)
- PARD3 (30)
- RBFOX2 (30)
- SEMA6D (30)
- SEPT9 (30)
- SMOX (30)
- DCLK1 (29)
- ABL2 (28)
- ABLIM2 (28)
- CNOT4 (28)
- DMD (28)
- EDA (28)
- ENSA (28)
- GPM6B (28)
- KCNIP2 (28)
- MECOM (28)
- MEN1 (28)
- NCALD (28)
- PCBP2 (28)
- PDLIM5 (28)
- PFKFB3 (28)
- PML (28)
- RBFOX1 (28)
- ST3GAL3 (28)
- STAU2 (28)
- STRA6 (28)
- TCF3 (28)
- TFDP2 (28)
- TNNT3 (28)
- ADGRG1 (26)
- APP (26)
- ARHGEF7 (26)
- AURKA (26)
- CACNB2 (26)
- CD1E (26)
- CD36 (26)
- DMKN (26)
- DNMT3B (26)
- ELAVL4 (26)
- IL32 (26)
- IRF5 (26)
- LDB3 (26)
- LY6E (26)
- MADD (26)
- MAPK9 (26)
- MUC1 (26)
- NF2 (26)
Species
Lentivirus
Vectors
Mutants
Mammalian Cell Selection
Families
- Druggable Genome (33674)
- Transmembrane (20947)
- Transcription Factors (8411)
- Secreted Protein (5697)
- Protein Kinase (2979)
- Protease (2138)
- ES Cell Differentiation/IPS (2021)
- GPCR (1544)
- Stem cell - Pluripotency (1544)
- Phosphatase (894)
- Ion Channels: Other (642)
- Adult stem cells (463)
- Nuclear Hormone Receptor (412)
- Embryonic stem cells (399)
- Ion Channels: Potassium (366)
- Cancer stem cells (240)
- Induced pluripotent stem cells (227)
- Ion Channels: Cys-loop Receptors (226)
- P450 (220)
- Ion Channels: Transient receptor potential (150)
- Stem cell relevant signaling - JAK/STAT signaling pathway (136)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (128)
- Ion Channels: Glutamate Receptors (104)
- Stem cell relevant signaling - Wnt Signaling pathway (98)
- Stem cell relevant signaling - DSL/Notch pathway (92)
- Ion Channels: Sodium (43)
- Ion Channels: ATP Receptors (40)
- Ion Channels: Cyclic nucleotide gated (30)
- Ion Channels: Calcium (11)
Pathways
- Metabolic pathways (4907)
- Pathways in cancer (2126)
- MAPK signaling pathway (1652)
- Neuroactive ligand-receptor interaction (1410)
- Cytokine-cytokine receptor interaction (1403)
- Regulation of actin cytoskeleton (1198)
- Focal adhesion (1058)
- Endocytosis (1025)
- Chemokine signaling pathway (1013)
- Calcium signaling pathway (929)
- Wnt signaling pathway (922)
- Olfactory transduction (918)
- Neurotrophin signaling pathway (875)
- Jak-STAT signaling pathway (807)
- Huntington's disease (794)
- Purine metabolism (783)
- Natural killer cell mediated cytotoxicity (782)
- Ubiquitin mediated proteolysis (780)
- Alzheimer's disease (778)
- Insulin signaling pathway (741)
- Axon guidance (732)
- Leukocyte transendothelial migration (710)
- Cell adhesion molecules (CAMs) (709)
- Progesterone-mediated oocyte maturation (690)
- T cell receptor signaling pathway (682)
- Tight junction (677)
- Cell cycle (674)
- Oocyte meiosis (642)
- Toll-like receptor signaling pathway (632)
- ErbB signaling pathway (631)
- Prostate cancer (601)
- Melanogenesis (589)
- Lysosome (587)
- Apoptosis (583)
- Adherens junction (572)
- GnRH signaling pathway (569)
- Fc gamma R-mediated phagocytosis (565)
- Vascular smooth muscle contraction (556)
- Colorectal cancer (549)
- Hematopoietic cell lineage (543)
- Pancreatic cancer (530)
- Parkinson's disease (503)
- VEGF signaling pathway (501)
- Dilated cardiomyopathy (497)
- Spliceosome (497)
- B cell receptor signaling pathway (492)
- Melanoma (484)
- Chronic myeloid leukemia (478)
- Systemic lupus erythematosus (472)
- TGF-beta signaling pathway (469)
- Gap junction (466)
- Hypertrophic cardiomyopathy (HCM) (465)
- Oxidative phosphorylation (464)
- Small cell lung cancer (454)
- Renal cell carcinoma (451)
- Fc epsilon RI signaling pathway (450)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (438)
- p53 signaling pathway (437)
- RIG-I-like receptor signaling pathway (424)
- Glioma (417)
- Acute myeloid leukemia (415)
- Adipocytokine signaling pathway (412)
- Antigen processing and presentation (408)
- NOD-like receptor signaling pathway (405)
- Pyrimidine metabolism (405)
- PPAR signaling pathway (404)
- Long-term potentiation (399)
- Viral myocarditis (377)
- Long-term depression (376)
- Complement and coagulation cascades (366)
- Epithelial cell signaling in Helicobacter pylori infection (365)
- Endometrial cancer (358)
- Amyotrophic lateral sclerosis (ALS) (349)
- Non-small cell lung cancer (342)
- Phosphatidylinositol signaling system (340)
- Ribosome (336)
- ECM-receptor interaction (325)
- mTOR signaling pathway (323)
- Glycolysis / Gluconeogenesis (322)
- Glycerophospholipid metabolism (320)
- Basal cell carcinoma (314)
- Cardiac muscle contraction (312)
- Pathogenic Escherichia coli infection (304)
- Bladder cancer (302)
- Drug metabolism - cytochrome P450 (296)
- Hedgehog signaling pathway (296)
- Metabolism of xenobiotics by cytochrome P450 (294)
- Vibrio cholerae infection (292)
- Cytosolic DNA-sensing pathway (290)
- Type II diabetes mellitus (270)
- Arginine and proline metabolism (268)
- Retinol metabolism (260)
- Arachidonic acid metabolism (244)
- Inositol phosphate metabolism (242)
- Thyroid cancer (242)
- Valine (242)
- Drug metabolism - other enzymes (240)
- Glutathione metabolism (234)
- Starch and sucrose metabolism (224)
- Autoimmune thyroid disease (222)
- RNA degradation (218)
- N-Glycan biosynthesis (216)
- Sphingolipid metabolism (216)
- Tyrosine metabolism (212)
- Amino sugar and nucleotide sugar metabolism (208)
- Primary immunodeficiency (204)
- leucine and isoleucine degradation (204)
- Lysine degradation (203)
- Glycerolipid metabolism (200)
- Pyruvate metabolism (198)
- Notch signaling pathway (196)
- Fatty acid metabolism (194)
- Type I diabetes mellitus (194)
- Nucleotide excision repair (193)
- Tryptophan metabolism (190)
- ABC transporters (188)
- Taste transduction (188)
- Proteasome (187)
- Cysteine and methionine metabolism (184)
- Prion diseases (178)
- Base excision repair (173)
- Graft-versus-host disease (172)
- Ether lipid metabolism (170)
- Androgen and estrogen metabolism (166)
- Fructose and mannose metabolism (166)
- SNARE interactions in vesicular transport (164)
- Alanine (162)
- aspartate and glutamate metabolism (162)
- Citrate cycle (TCA cycle) (160)
- Allograft rejection (158)
- Regulation of autophagy (152)
- Porphyrin and chlorophyll metabolism (150)
- Glycine (146)
- serine and threonine metabolism (146)
- Butanoate metabolism (144)
- Maturity onset diabetes of the young (144)
- Propanoate metabolism (144)
- Galactose metabolism (139)
- Aminoacyl-tRNA biosynthesis (138)
- Glycosphingolipid biosynthesis - lacto and neolacto series (136)
- DNA replication (135)
- Nitrogen metabolism (130)
- Pentose phosphate pathway (126)
- Dorso-ventral axis formation (124)
- Glycosaminoglycan degradation (122)
- Histidine metabolism (122)
- Homologous recombination (122)
- Linoleic acid metabolism (122)
- O-Glycan biosynthesis (120)
- Basal transcription factors (116)
- Selenoamino acid metabolism (114)
- Asthma (106)
- Phenylalanine metabolism (106)
- Nicotinate and nicotinamide metabolism (103)
- Mismatch repair (102)
- Biosynthesis of unsaturated fatty acids (96)
- beta-Alanine metabolism (96)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (94)
- Heparan sulfate biosynthesis (92)
- Pentose and glucuronate interconversions (92)
- Renin-angiotensin system (92)
- Primary bile acid biosynthesis (90)
- RNA polymerase (89)
- Ascorbate and aldarate metabolism (84)
- One carbon pool by folate (84)
- Keratan sulfate biosynthesis (82)
- Riboflavin metabolism (81)
- alpha-Linolenic acid metabolism (80)
- Other glycan degradation (76)
- Non-homologous end-joining (74)
- Steroid biosynthesis (74)
- Pantothenate and CoA biosynthesis (73)
- Glycosphingolipid biosynthesis - globo series (72)
- Terpenoid backbone biosynthesis (70)
- Chondroitin sulfate biosynthesis (68)
- Sulfur metabolism (68)
- Circadian rhythm - mammal (66)
- Glycosphingolipid biosynthesis - ganglio series (66)
- Glyoxylate and dicarboxylate metabolism (64)
- C21-Steroid hormone metabolism (58)
- Limonene and pinene degradation (58)
- leucine and isoleucine biosynthesis (58)
- Folate biosynthesis (52)
- Taurine and hypotaurine metabolism (50)
- Cyanoamino acid metabolism (48)
- Protein export (44)
- Caffeine metabolism (40)
- Thiamine metabolism (38)
- Fatty acid elongation in mitochondria (36)
- Methane metabolism (36)
- Synthesis and degradation of ketone bodies (36)
- Ubiquinone and other terpenoid-quinone biosynthesis (26)
- Vitamin B6 metabolism (20)
- Fatty acid biosynthesis (17)
- Lipoic acid metabolism (16)
- O-Mannosyl glycan biosynthesis (16)
- Phenylalanine (16)
- tyrosine and tryptophan biosynthesis (16)
- D-Glutamine and D-glutamate metabolism (14)
- Lysine biosynthesis (12)
- Biotin metabolism (6)
- D-Arginine and D-ornithine metabolism (4)